Frequent deletions within FRA7G at 7q31.2 in Invasive epithelial ovarian cancer

Haojie Huang, Christopher P. Reed, Aderonke Mordi, Gwen Lomberk, Liang Wang, Vijayalakshmi Shridhar, Lynn Hartmann, Robert Brian Jenkins, David I Smith

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

We previously showed that FRA7G, an aphidicolin-inducible common fragile site at 7q31.2, colocalized with the common region of loss of heterozygosity (LOH) in a number of different tumors. Based on the sequence analysis of 150 Kb in the FRA7G region, we identified four new polymorphic microsatellite markers. In this article, we have used these four microsatellite markers and eight additional markers from 7q22-32 to analyze the breakage and loss of the region surrounding FRA7G in 49 invasive epithelial ovarian cancers and three borderline ovarian tumors. No allelic loss was detected in the ovarian tumors of borderline malignancy, but 71% (35/49) of the invasive tumors showed LOH at one or more loci in the region analyzed. Of the 12 markers analyzed, most of the markers exhibiting a high frequency of LOH were within FRA7G, and the highest frequency of LOH was seen with the new marker 7G14 (37%, 15/41). Breakpoint analysis in tumors with LOH demonstrated that the frequent loss of DNA sequences seen within the FRA7G region was due to frequent small interstitial deletions and not a result of loss of the whole fragile site region. These findings indicate that FRA7G does play a role in the breakage and loss of 7q sequences in invasive ovarian cancer. In addition, the newly identified markers enable us to further delineate a smallest common region of loss in invasive ovarian tumors to a 150-Kb region flanked by markers D7S486 and 7G14.

Original languageEnglish (US)
Pages (from-to)48-55
Number of pages8
JournalGenes Chromosomes and Cancer
Volume24
Issue number1
DOIs
StatePublished - Jan 1999

Fingerprint

Loss of Heterozygosity
Neoplasms
Microsatellite Repeats
Aphidicolin
Ovarian epithelial cancer
Ovarian Neoplasms
Sequence Analysis

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Frequent deletions within FRA7G at 7q31.2 in Invasive epithelial ovarian cancer. / Huang, Haojie; Reed, Christopher P.; Mordi, Aderonke; Lomberk, Gwen; Wang, Liang; Shridhar, Vijayalakshmi; Hartmann, Lynn; Jenkins, Robert Brian; Smith, David I.

In: Genes Chromosomes and Cancer, Vol. 24, No. 1, 01.1999, p. 48-55.

Research output: Contribution to journalArticle

Huang, Haojie ; Reed, Christopher P. ; Mordi, Aderonke ; Lomberk, Gwen ; Wang, Liang ; Shridhar, Vijayalakshmi ; Hartmann, Lynn ; Jenkins, Robert Brian ; Smith, David I. / Frequent deletions within FRA7G at 7q31.2 in Invasive epithelial ovarian cancer. In: Genes Chromosomes and Cancer. 1999 ; Vol. 24, No. 1. pp. 48-55.
@article{8efd4c4de6d049d38eeb05cb44a6a233,
title = "Frequent deletions within FRA7G at 7q31.2 in Invasive epithelial ovarian cancer",
abstract = "We previously showed that FRA7G, an aphidicolin-inducible common fragile site at 7q31.2, colocalized with the common region of loss of heterozygosity (LOH) in a number of different tumors. Based on the sequence analysis of 150 Kb in the FRA7G region, we identified four new polymorphic microsatellite markers. In this article, we have used these four microsatellite markers and eight additional markers from 7q22-32 to analyze the breakage and loss of the region surrounding FRA7G in 49 invasive epithelial ovarian cancers and three borderline ovarian tumors. No allelic loss was detected in the ovarian tumors of borderline malignancy, but 71{\%} (35/49) of the invasive tumors showed LOH at one or more loci in the region analyzed. Of the 12 markers analyzed, most of the markers exhibiting a high frequency of LOH were within FRA7G, and the highest frequency of LOH was seen with the new marker 7G14 (37{\%}, 15/41). Breakpoint analysis in tumors with LOH demonstrated that the frequent loss of DNA sequences seen within the FRA7G region was due to frequent small interstitial deletions and not a result of loss of the whole fragile site region. These findings indicate that FRA7G does play a role in the breakage and loss of 7q sequences in invasive ovarian cancer. In addition, the newly identified markers enable us to further delineate a smallest common region of loss in invasive ovarian tumors to a 150-Kb region flanked by markers D7S486 and 7G14.",
author = "Haojie Huang and Reed, {Christopher P.} and Aderonke Mordi and Gwen Lomberk and Liang Wang and Vijayalakshmi Shridhar and Lynn Hartmann and Jenkins, {Robert Brian} and Smith, {David I}",
year = "1999",
month = "1",
doi = "10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V",
language = "English (US)",
volume = "24",
pages = "48--55",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Frequent deletions within FRA7G at 7q31.2 in Invasive epithelial ovarian cancer

AU - Huang, Haojie

AU - Reed, Christopher P.

AU - Mordi, Aderonke

AU - Lomberk, Gwen

AU - Wang, Liang

AU - Shridhar, Vijayalakshmi

AU - Hartmann, Lynn

AU - Jenkins, Robert Brian

AU - Smith, David I

PY - 1999/1

Y1 - 1999/1

N2 - We previously showed that FRA7G, an aphidicolin-inducible common fragile site at 7q31.2, colocalized with the common region of loss of heterozygosity (LOH) in a number of different tumors. Based on the sequence analysis of 150 Kb in the FRA7G region, we identified four new polymorphic microsatellite markers. In this article, we have used these four microsatellite markers and eight additional markers from 7q22-32 to analyze the breakage and loss of the region surrounding FRA7G in 49 invasive epithelial ovarian cancers and three borderline ovarian tumors. No allelic loss was detected in the ovarian tumors of borderline malignancy, but 71% (35/49) of the invasive tumors showed LOH at one or more loci in the region analyzed. Of the 12 markers analyzed, most of the markers exhibiting a high frequency of LOH were within FRA7G, and the highest frequency of LOH was seen with the new marker 7G14 (37%, 15/41). Breakpoint analysis in tumors with LOH demonstrated that the frequent loss of DNA sequences seen within the FRA7G region was due to frequent small interstitial deletions and not a result of loss of the whole fragile site region. These findings indicate that FRA7G does play a role in the breakage and loss of 7q sequences in invasive ovarian cancer. In addition, the newly identified markers enable us to further delineate a smallest common region of loss in invasive ovarian tumors to a 150-Kb region flanked by markers D7S486 and 7G14.

AB - We previously showed that FRA7G, an aphidicolin-inducible common fragile site at 7q31.2, colocalized with the common region of loss of heterozygosity (LOH) in a number of different tumors. Based on the sequence analysis of 150 Kb in the FRA7G region, we identified four new polymorphic microsatellite markers. In this article, we have used these four microsatellite markers and eight additional markers from 7q22-32 to analyze the breakage and loss of the region surrounding FRA7G in 49 invasive epithelial ovarian cancers and three borderline ovarian tumors. No allelic loss was detected in the ovarian tumors of borderline malignancy, but 71% (35/49) of the invasive tumors showed LOH at one or more loci in the region analyzed. Of the 12 markers analyzed, most of the markers exhibiting a high frequency of LOH were within FRA7G, and the highest frequency of LOH was seen with the new marker 7G14 (37%, 15/41). Breakpoint analysis in tumors with LOH demonstrated that the frequent loss of DNA sequences seen within the FRA7G region was due to frequent small interstitial deletions and not a result of loss of the whole fragile site region. These findings indicate that FRA7G does play a role in the breakage and loss of 7q sequences in invasive ovarian cancer. In addition, the newly identified markers enable us to further delineate a smallest common region of loss in invasive ovarian tumors to a 150-Kb region flanked by markers D7S486 and 7G14.

UR - http://www.scopus.com/inward/record.url?scp=0032889647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032889647&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V

DO - 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V

M3 - Article

C2 - 9892108

AN - SCOPUS:0032889647

VL - 24

SP - 48

EP - 55

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 1

ER -